liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Hur påverkar amifostin topotecan vid samtidig administrering. En randomiserad fas II och farmakokinetisk studie
Linköping University, Faculty of Health Sciences. Linköping University, Department of Medicine and Care, Clinical Pharmacology.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Medicine and Care, Clinical Pharmacology. Östergötlands Läns Landsting, Centre for Laboratory Medicine, Department of Clinical Pharmacology.
2000 (English)In: Läkarstämman,2000, Stockholm: Svenska läkaresällskapet , 2000Conference paper, Published paper (Other academic)
Place, publisher, year, edition, pages
Stockholm: Svenska läkaresällskapet , 2000.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-28321Local ID: 13454OAI: oai:DiVA.org:liu-28321DiVA: diva2:249127
Available from: 2009-10-09 Created: 2009-10-09

Open Access in DiVA

No full text

Authority records BETA

Zackrisson, Anna LenaPeterson, Curt

Search in DiVA

By author/editor
Zackrisson, Anna LenaPeterson, Curt
By organisation
Faculty of Health SciencesClinical PharmacologyDepartment of Clinical Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 85 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf